在缺血性损伤中TLR-4介导NF-κB炎症通路的治疗相关性
Veerta Sharma1, Prateek Sharma1, Thakur Gurjeet Singh1
1Chitkara College of Pharmacy, Chitkara University, Punjab, India.
Current drug targets
|September 16, 2024
概括
缺血-再输液损伤会导致由于炎症导致的显著组织损伤. 收费类受体-4 (TLR-4) 和核因子kappa-B (NF-κB) 信号通路是这种炎症的关键驱动因素,提供治疗点.
科学领域:
- 免疫学 免疫学 免疫学
- 病理生理学 病理生理学
- 药理学 药理学是指药理学的学科.
背景情况:
- 缺血-再输液 (I/R) 损伤在中风和心脏病发作等情况下会导致组织损伤.
- 过度的炎症是I / R损伤的标志.
- 收费类受体 (TLRs) 导致损伤中的炎症,而不仅仅是感染.
研究的目的:
- 为了阐明TLRs在I/R损伤中的信号通路.
- 详细介绍TLR-4/NF-κB在I/R病理生理学中的作用.
- 审查针对TLR-4/NF-κB进行I/R损伤的药理学药剂.
主要方法:
- 对当前的研究和实验进行了全面的审查.
- 对TLR-4/NF-κB信号级联的分析.
- 对TLR-4/NF-κB抑制剂的鉴定和分类.
主要成果:
- TLR-4的激活导致NF-κB的激活.
- NF-κB刺激促炎性细胞因子和化学因子的产生,恶化I/R损伤.
- 特定的TLR-4/NF-κB抑制剂在各种I/R损伤中显示出治疗潜力.
结论:
- TLR-4/NF-κB信号传递是I/R损伤病理生理学的核心.
- 针对TLR-4/NF-κB为I/R损伤提供了一个有前途的治疗策略.
- 需要进一步的研究来完善向疗法并改善患者的治疗结果.
相关概念视频
NF-κB-dependent Signaling Pathway
7.4K
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
NF-κB-dependent Signaling Mechanism
The...
7.4K
Inflammatory Response
1.9K
An inflammatory response is a localized, nonspecific immune reaction that occurs when a tissue is injured. It is characterized by redness, swelling, heat, and pain, which are commonly called the cardinal signs and symptoms of inflammation. Inflammation can sometimes result in a loss of function.
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
1.9K
Inflammation
53.2K
Overview
53.2K
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
120
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
120
The JAK-STAT Signaling Pathway
8.7K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
8.7K
T Cell Types and Functions
961
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
961


